12 May 2020 Fein covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Constellation Pharmaceuticals, and Graphique d'action AIMT LONG AIMT Tendance 3 mois (janv 18) · AIMT, D Un dirigeant du réseau Reddit demande à être remplacé par une personne noire 9 Jan 2020 The week closes with a PDUFA date for Aimmune Therapeutics Inc (NASDAQ: AIMT). Here's what's happening: Continue Reading. Click below to (AIMT) Company Bio. Aimmune Therapeutics is a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut 26 Dec 2019 With a market capitalization just over $2 billion and a share price near $32, AIMT is still a relatively small company. But for 2019, it's up 32.6%, Managing Partner at CG Life and a premium CLSA Member, shares insights (BUSINESS WIRE)–Oct. 7, 2015– Aimmune Therapeutics, Inc. (Nasdaq:AIMT), 11 May 2020 BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), The weighted average shares outstanding for the quarter ended March 31,
View detailed financial information, real-time news, videos, quotes and analysis on Aimmune Therapeutics Inc. (NASDAQ:AIMT). Explore commentary on …
AIMT, Aimmune Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines AIMT - Aimmune Therapeutics Inc Stock quote - CNNMoney.com Find real-time AIMT - Aimmune Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Aimmune Therapeutics Stock Forecast: down to 15.166 USD ...
AIMT Aimmune Therapeutics, Inc. Common Stock. Data is currently not available. $17.98. 0.12 (0.67%) DATA AS OF Jun 05, 2020. Latest News. Why Are So Many Traders Betting Against the First Therapy
Jun 09, 2020 Aimmune Therapeutics, Inc. Common Stock (AIMT) Stock ... May 16, 2020 AIMT Insider Trading Activity (Aimmune Therapeutics) Which company executives are buying and selling shares of Aimmune Therapeutics (NASDAQ:AIMT) stock? View the most recent insider trading activity for AIMT stock at MarketBeat.
The stock has gained 5.2% year to date through Tuesday, while the SPDR Consumer Staples Select Sector ETF has lost 5.1% and the S&P 500 has declined 4.6%. Jun. 3, 2020 at 7:17 a.m. ET by Tomi Kilgore
AIMT: Aimmune Therapeutics Inc - Zacks Investment Research AIMT: Aimmune Therapeutics Inc broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. AIMT:NASDAQ GS Stock Quote - Aimmune Therapeutics Inc ...
AIMT: Get the latest Aimmune Therapeutics stock price and detailed information including AIMT news, historical charts and realtime prices.
Aimmune Therapeutics - AIMT - Stock Price & News | The ... Real time Aimmune Therapeutics (AIMT) stock price quote, stock graph, news & analysis. AIMT Stock Analysis: Price, Forecast, and News AIMT Stock Analysis Overview . What this means: Aimmune Therapeutics Inc (AIMT) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. AIMT dividend announcements Aimmune Therapeutics, Inc ... Dividends will be given to all the share holders of Aimmune Therapeutics, Inc. AIMT who hold shares in their accounts on the above mentioned effective dividend dates . Also check Latest NEWS for Aimmune Therapeutics, Inc. and Stock Tips for Aimmune Therapeutics, Inc. or you can view charts of Aimmune Therapeutics, Inc. using the links below ACST Acasti Pharma Inc. — Stock Price and Discussion ...